Inventor
NICHOLAS D. SMITH
Inventor
US
Overview
Patents· 6 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes30%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations30%
C07DHeterocyclic compounds25%
C07BGeneral methods of organic chemistry10%
C07CAcyclic or carbocyclic compounds5%
PatentTitleYear
12,545,660Crystalline forms of a farnesoid X receptor agonist202612,491,160Formulations of a farnesoid X receptor agonist202512,018,008Crystalline forms of an androgen receptor modulator202411,773,094Farnesoid X receptor agonists and uses thereof202311,236,071Farnesoid X receptor agonists and uses thereof202211,214,538Farnesoid X receptor agonists and uses thereof2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2023Patents assigned to METACRINE INC (3)· patent assignee history
2022–2026Based in US· patent location history
2023Patents assigned to ORGANOVO INC (1)· patent assignee history
2024Patents assigned to ARAGON PHARMACEUTICALS INC (1)· patent assignee history
2024Patents assigned to SLOAN KETTERING INST CANCER RES (1)· patent assignee history
2025–2026Patents assigned to LILLY CO ELI (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| METACRINE INC | 3 | 2022–2023 |
| LILLY CO ELI | 2 | 2025–2026 |
| ARAGON PHARMACEUTICALS INC | 1 | 2024 |
| ORGANOVO INC | 1 | 2023 |
| SLOAN KETTERING INST CANCER RES | 1 | 2024 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 6 | 2022–2026 |